The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humans

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2759-2764

  Helbecque, Nicole ^a   Dallongeville, Jean ^a   Codron, Valérie ^a   Arveiler, Dominique ^b   Ruidavets, Jean Bernard ^c   Evans, Alun ^d   Cambien, François ^e   Fruchart, Jean Charles ^a   Amouyel, Philippe ^a,e  

^a INSTITUT PASTEUR DE LILLE   (France)

^b Lab d'Epidemiol et de S Pub   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e INSERM   (France)

Author keywords

Lipoprotein metabolism; Polymorphism; Triglyceride rich lipoproteins; VLDL receptor

Indexed keywords

APOLIPOPROTEIN E; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; REPETITIVE DNA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031442988     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2759     Document Type: Article

References (18)

1. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci. U.S.A. 1992;89:9252-9256.
2. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-47.
3. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK. Surface location and high affinity for calcium of a 500 kDa liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 1988;7: 4119-4127.
4. Raychowdhury R, Niles JL, McCluskey RT, Smith JA. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDLR. Science. 1989;244:1163-1165.
5. Tensen CP, Van Kesteren ER, Planta RJ, Cox, KJA, Burke JF, Van Heerikhuizen H, Vreugdenhil E. A G-protein coupled receptor with low density lipoprotein- binding motifs suggests a role for lipoproteins in G-linked signal transduction. Proc Natl Acad Sci U S A. 1994;91:4816-4820.
6. Kim DH, Iijima H, Goto K, Sakai J, Ishii H, Hyoun-Ju K, Suzuki H, Kondo H, Saeki S, Yamamoto T. Human apolipoprotein E receptor 2. J Biol Chem. 1996;271:8373-8380.
7. Sakai J, Hoshino A, Takahashi S, Miura Y, Ishii H, Suzuki H, Kawarabayashi Y, Yamamoto T. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J Biol Chem. 1994;269:2173-2182.
8. Okuizimi K, Onodera O, Namba Y, Ikeda K, Yamamoto T, Seki K, Ueki A, Nanko S, Tanaka H, Takahashi H, Oyanagi K, Mizusawa H, Kanazawa I, Tsuji S. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Genet. 1995;11:207-209.
9. Chung H, Roberts CT, Greenberg S, Rebeck W, Christie R, Wallace R, Jacob HJ, Hyman BT. Lack of association of trinucleotide repeat polymorphisms in the very- low-density lipoprotein receptor gene with Alzheimer's disease. Ann Neurol. 1996;39: 800-803.
10. Okuizumi K, Onodera O, Seki K, Tanaka H, Namba Y, Ikeda K, Saunders AM, Pericak-Vance MA, Roses AD, Tsuji S. Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann Neurol. 1996; 40:251-254.
11. Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of apoA- and apoB-containing lipoprotein families. Prog Lipid Res. 1991;30:105-138.
12. Agnani G, Bard JM, Candelier L, Delattre S, Fruchart JC, Clavey V. Interaction of LpB, LpB:E, LpC-III:B and LpB:C-III:E lipoproteins with the low density lipoprotein receptor on HeLa cells. Arteriosclerosis. 1991;11:1021-1029.
13. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G, Richard JL, Ducimetière P, Fruchart JC, Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb. 1992; 12:701-707.
14. Kandoussi A, Cachera C, Parsy D, Bard JM, Fruchart JC. Quantitative determination of different apolipoprotein B-containing lipoproteins by an enzyme- linked immunosorbent assay: apoB with apoC-III and apoB with apoE. J Immunoassay. 1991;12:305-323.
15. Leroy A, VuDac N, Koffigan M, Clavey V, Fruchart JC. Characterization of monoclonal antibody that binds to apoE and lipoprotein of human plasma containing apoE. J Immunol. 1988;9 309-334.
16. Parsy D, Clavey V, Fievet C, Kora I, Duriez P, Fruchart JC. Quantification of apolipoprotein C-III in serum by noncompetitive immunoenzymometric assay. Clin Chem. 1985;31:1632-1635.
17. Parra HJ, Mezdour H, Ghalin N, Bard JM, Fruchart JC. Differential electroimmunoassay of LpA-I lipoprotein particles on ready-to-use plates. Clin Chem. 1990;36:1431-1435.
18. Saiki RK, Scharf SJ, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350-1354.